Skip to main content
logo
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.910
-0.200 (-4.87%)
Aug 26, 2026, 3:24 PM EDT - Market open

Opus Genetics Revenue

Opus Genetics had revenue of $755.00K in the quarter ending June 30, 2026, a decrease of -73.80%. This brings the company's revenue in the last twelve months to $9.86M, down -36.09% year-over-year. In the year 2025, Opus Genetics had annual revenue of $14.20M with 29.15% growth.

Revenue (ttm)
$9.86M
Revenue Growth
-36.09%
P/S Ratio
33.17
Revenue / Employee
$352,000
Employees
28
Market Cap
325.30M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.20M3.20M29.15%
Dec 31, 202410.99M-8.06M-42.30%
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 200875.00K--
Dec 31, 200775.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals215.72M
Sutro Biopharma45.70M
Orchestra BioMed Holdings31.98M
Abeona Therapeutics25.52M
ProQR Therapeutics21.05M
YD Bio510.36K
Palisade Bio500.00K
SAB Biotherapeutics114.70K
Revenue Rankings

IRD News

More News